OccuLogix Conducting Rheo Clinical Trial, Crossover Studies Simultaneously
This article was originally published in The Pink Sheet Daily
Executive Summary
OccuLogix' Rheo "dry" age-related macular degeneration therapy pivotal clinical trial enrollment is complete, moving the firm closer to PMA submission. OccuLogix projects device approval in mid-2006.